“The global infectious disease diagnostics market is projected to grow at a CAGR of 5.6%.”
The global infectious disease diagnostics market is expected to reach USD 19.35 billion by 2022 from USD 14.73 billion in 2017, at a CAGR of 5.6%. Growth in this market can primarily be attributed to factors such as increasing global prevalence of infectious diseases, shift in focus from centralized laboratories to decentralized point-of-care testing, and growth in funding for research on infectious disease diagnostics. However, inadequate reimbursement and rising healthcare cost limiting usage of novel diagnostic technologies are expected to restrain the growth of this market during the forecast period.
Request a Free Sample copy of This Premium Research Report: https://watchersofmarkets.com/collections/marketsandmarkets/products/infectious-disease-diagnostics-market-by-product-service-assay-kit-reagent-instruments-disease-type-hepatitis-hiv-hai-hpv-tb-influenza-technology-immunodiagnostics-pcr-ngs-end-user-hospital-research-institute-global-forecast-to#tab-questions
“The assays, kits, & reagents segment accounted for the largest share in 2017.”
Based on product & service, the infectious disease diagnostics market is segmented into assays, kits, & reagents; instruments; and services & software. The assays, kits, and reagents segment accounted for the largest share of the global infectious disease diagnostics market in 2017. The large share of this segment can be attributed to the increasing number of infectious disease diagnostic tests carried out; easy accessibility to a wide range of reagents; and the growing need for reliable, specific, and faster detection of infectious diseases in the early stages.
“Asia Pacific is projected to grow at the highest CAGR during the forecast period.”
Geographically, Asia Pacific is expected to register the highest CAGR during the forecast period. The growth of this regional segment can be attributed to the growing GDPs and a significant rise in disposable income levels, increased healthcare spending by a larger population base, modernization of healthcare infrastructure, and rising penetration of cutting-edge clinical laboratory technologies (especially in rural areas).
Break-up profile of primaries:
• By Company Type- Tier 40%, Tier 30%, and Tier 30%
• By Designation-C-level-27%, D-level-18%, and Others-55%
• By Region-North America-50%, Europe-20%, Asia Pacific-20%, and RoW-10%
The key players in the global infectious disease diagnostics market are Abbott (US), Becton, Dickinson and Company (BD) (US), bioMerieux (France), Bio-Rad (US), and Roche (Switzerland).
Research Coverage:
The infectious disease diagnostics market in this report is segmented by product & service, disease type, technology, end user, and region. The study tracks and analyzes competitive developments such as product launches & approvals, acquisitions, collaborations, agreements, partnerships, and expansions, and profiles key players and core competencies in the infectious disease diagnostics market.
Reasons to buy this report:
The report provides insights on the following pointers:
Market Penetration: Comprehensive information on portfolios offered by the top players in the global infectious disease diagnostics market. The report analyzes the market by product & service, disease type, technology, end user, and region
Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the global infectious disease diagnostics market
Market Development: Comprehensive information about lucrative emerging markets—the report analyzes the markets for infectious disease diagnostic products across regions
Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the global infectious disease diagnostics market
Competitive Assessment: In-depth assessment of strategies, products, and manufacturing capabilities of the key players in the global infectious disease diagnostics market
Related report:
Molecular Diagnostics Market by Application (Infectious Disease (HIV HBV TB) Oncology Genetics Microbiology) Technology (PCR Hybridization DNA Sequencing) End User (Hospitals Laboratory) Product & Service (Reagent Software) - Forecast to 2021
The global molecular diagnostics market is projected to reach USD 10.12 billion by 2021 from USD 6.54 billion in 2016, at a CAGR of 9.1% from 2016 to 2021. High prevalence of infectious diseases and various types of cancer, increasing awareness and acceptance of personalized medicine and companion diagnostics, growth in the biomarker identification market and advancements in molecular techniques; and reforms in the reimbursement system in the U.S. are the major factors driving the growth of the molecular diagnostics market. Advances in genomics and proteomics, increasing adoption of point-of-care testing, developing markets in Asia-Pacific such as China, India, Brazil, Mexico, and South Africa offer lucrative opportunities for players in the molecular diagnostics market.
About Us:
We are one of the world's largest market research store bridging you with market research insights, analysis and data from many market research publishers around the globe.
Our experienced market research consultants, from our headquarters (Den Haag, Netherlands) understand client’s research requirements in precise manner and get many proposals on the table suiting your budget and mapping your research goals. Our only motives is to provide clients with precise insights into their respective niche markets; offering them the most comprehensive portfolio of business information products.
Contact:
Watchers of Markets
Henriëtte van der Meydreef 144,2492 JG, Den Haag, Netherlands.
Website:- https://watchersofmarkets.com/
Phone number: +31- 85 888 111 6
Email Id :- [email protected]